Lifevantage (NASDAQ:LFVN) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Posted by Brenda Bartman on Nov 11th, 2026

Lifevantage (NASDAQ:LFVN – Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.01), FiscalAI reports. The company had revenue of $37.12 million during the quarter, compared to the consensus estimate of $40.49 million. Lifevantage had a net margin of 1.58% and a return on equity of 16.34%.

Here are the key takeaways from Lifevantage’s conference call:

Revenue and earnings fell sharply: First-quarter revenue declined 22% year over year to $37.1 million as orders and average order size decreased. Adjusted EBITDA fell to $1.9 million from $3.9 million, and the company reported a GAAP operating loss.
Management laid out a broad transformation plan focused on repositioning the brand, improving the digital consumer experience, and making the business more efficient. Planned launches include a new North American website and digital platform in calendar Q2 2027, followed by seller tools in Q3.
The company has a solid financial cushion: It ended the quarter with $13.7 million in cash, no debt, and $0.5 million in cash from operations. Management said it expects operating cash flow to remain positive.
Subscription-based sales represented more than 75% of revenue, and management reported improved customer and consultant retention compared with the prior-year quarter. However, the company is not providing formal guidance while it works through its strategy and fiscal-year transition.

Lifevantage Stock Performance

NASDAQ LFVN opened at $4.56 on Wednesday. The company has a fifty day moving average of $6.00 and a 200-day moving average of $5.87. Lifevantage has a 52-week low of $3.90 and a 52-week high of $11.71. The company has a market capitalization of $57.41 million, a P/E ratio of 12.30 and a beta of 0.71.

Lifevantage Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date of this dividend is Tuesday, December 1st. Lifevantage’s dividend payout ratio (DPR) is currently 50.00%.

Insider Activity

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of the company’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $6.18, for a total transaction of $55,008.18. Following the completion of the sale, the insider directly owned 120,162 shares in the company, valued at $742,601.16. This represents a 6.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 13.58% of the company’s stock.

Analyst Upgrades and Downgrades

LFVN has been the topic of several recent analyst reports. Lake Street Capital boosted their target price on shares of Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a report on Friday, August 28th. Weiss Ratings restated a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Finally, Zacks Research lowered Lifevantage from a “hold” rating to a “strong sell” rating in a report on Friday, October 16th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $5.50.

Read Our Latest Research Report on Lifevantage

Lifevantage Company Profile

(Get Free Report)

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care. The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.